bluebird bio, Inc. revenue breakdown overview

bluebird bio, Inc. revenue for the last year amounted to 74.47 M USD, the most of which — 83.80 M USD — came from its highest performing source at the moment, Gene Therapies, the year earlier bringing 29.07 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought bluebird bio, Inc. 83.81 M USD, and the year before that — 29.50 M USD.